The S100B/RAGE axis in alzheimer's disease

Cardiovascular Psychiatry and Neurology

Volumn , Issue , 2010, Pages

  Leclerc, Estelle ^a   Sturchler, Emmanuel ^b   Vetter, Stefan W ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PREALBUMIN; PROTEIN S100B; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; EPILEPTOGENESIS; GLIA CELL; INFLAMMATION; LEARNING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SPATIAL MEMORY; TRANSGENIC MOUSE;

EID: 77955971635     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2010/539581     Document Type: Review

References (156)

1. Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., Evans D. A., Alzheimer disease in the US population: prevalence estimates using the 2000 census Archives of Neurology 2003 60 8 1119 1122
2. Muller-Hill B., Beyreuther K., Molecular biology of Alzheimer's disease Annual Review of Biochemistry 1989 58 287 307
3. Glenner G. G., Wong C. W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochemical and Biophysical Research Communications 1984 120 3 885 890
4. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques Journal of the Neurological Sciences 1998 158 1 47 52
5. Kosik K. S., Joachim C. L., Selkoe D. J., Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1986 83 11 4044 4048
6. Thies E., Mandelkow E.-M., Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1 Journal of Neuroscience 2007 27 11 2896 2907
7. Vega I. E., Traverso E. E., Ferrer-Acosta Y., Matos E., Colon M., Gonzalez J., Dickson D., Hutton M., Lewis J., Yen S. H., A novel calcium-binding protein is associated with tau proteins in tauopathy Journal of Neurochemistry 2008 106 1 96 106
8. Supnet C., Bezprozvanny I., The dysregulation of intracellular calcium in Alzheimer disease Cell Calcium 2010 47 2 183 189
9. Mrak R. E., Griffin W. S. T., The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease Neurobiology of Aging 2001 22 6 915 922
10. Boom A., Pochet R., Authelet M., Pradier L., Borghgraef P., Van Leuven F., Heizmann C. W., Brion J.-P., Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models Biochimica et Biophysica Acta 2004 1742 13 161 168
11. Akiyama H., Ikeda K., Katoh M., McGeer E. G., McGeer P. L., Expression of MRP14, 27E10, interferon- and leukocyte common antigen by reactive microglia in postmortem human brain tissue Journal of Neuroimmunology 1994 50 2 195 201
12. Shepherd C. E., Goyette J., Utter V., Rahimi F., Yang Z., Geczy C. L., Halliday G. M., Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease Neurobiology of Aging 2006 27 11 1554 1563
13. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M., RAGE and amyloid- peptide neurotoxicity in Alzheimer's disease Nature 1996 382 6593 685 691
14. Miller M. C., Tavares R., Johanson C. E., Hovanesian V., Donahue J. E., Gonzalez L., Silverberg G. D., Stopa E. G., Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease Brain Research 2008 1230 273 280
15. Schmidt A. M., Vianna M., Gerlach M., Brett J., Ryan J., Kao J., Esposito C., Hegarty H., Hurley W., Clauss M., Wang F., Pan Y.-C. E., Tsang T. C., Stern D., Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface The Journal of Biological Chemistry 1992 267 21 14987 14997
16. Neeper M., Schmidt A. M., Brett J., Wang F., Pan Y.-C. E., Elliston K., Stern D., Shaw A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins The Journal of Biological Chemistry 1992 267 21 14998 15004
17. Ahmed N., Ahmed U., Thornalley P. J., Hager K., Fleischer G., Mnch G., Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment Journal of Neurochemistry 2005 92 2 255 263
18. Li J., Schmidt A. M., Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products The Journal of Biological Chemistry 1997 272 26 16498 16506
19. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P. M., Chen J., Hong M., Luther T., Henle T., Klting I., Morcos M., Hofmann M., Tritschler H., Weigle B., Kasper M., Smith M., Perry G., Schmidt A.-M., Stern D. M., Hring H.-U., Schleicher E., Nawroth P. P., Diabetes-associated sustained activation of the transcription factor nuclear factor- B Diabetes 2001 50 12 2792 2808 (Pubitemid 33733131)
20. Schmidt A.-M., Hofmann M., Taguchi A., Yan S. D., Stern D. M., RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation Seminars in Thrombosis and Hemostasis 2000 26 5 485 493
21. Dickson D. W., Sinicropi S., Yen S.-H., Ko L.-W., Mattiace L. A., Bucala R., Vlassara H., Glycation and microglial reaction in lesions of Alzheimer's disease Neurobiology of Aging 1996 17 5 733 743
22. Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fuj N. II, Koike T., Wakayama I., Yanagihara R., Garruto R., Amano N., Makita Z., Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases American Journal of Pathology 1998 153 4 1149 1155
23. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., Perry G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology Proceedings of the National Academy of Sciences of the United States of America 1994 91 12 5710 5714
24. Sousa M. M., Yan S. D., Stern D., Saraiva M. J., Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation Laboratory Investigation 2000 80 7 1101 1110
25. Strchler E., Galichet A., Weibel M., Leclerc E., Heizmann C. W., Site-specific blockade of RAGE-Vd prevents amyloid- oligomer neurotoxicity Journal of Neuroscience 2008 28 20 5149 5158
26. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A., McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D., Hori O., Ogawa S., Stern D. M., Yamada K., Yan S. S., RAGE-mediated signaling contributes to intraneuronal transport of amyloid- and neuronal dysfunction Proceedings of the National Academy of Sciences of the United States of America 2010 106 47 20021 20026
27. Deane R., Yan S. D., Submamaryan R. K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A. M., Armstrong D. L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B., RAGE mediates amyloid- peptide transport across the blood-brain barrier and accumulation in brain Nature Medicine 2003 9 7 907 913
28. Buxbaum J. N., Ye Z., Reixach N., Friske L., Levy C., Das P., Golde T., Masliah E., Roberts A. R., Bartfai T., Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of A toxicity Proceedings of the National Academy of Sciences of the United States of America 2008 105 7 2681 2686
29. Hori O., Brett J., Slattery T., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system The Journal of Biological Chemistry 1995 270 43 25752 25761
30. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., Coyle A. J., HMGB1 and RAGE in inflammation and cancer Annual Review of Immunology 2010 28 367 388
31. Heizmann C. W., Ackermann G. E., Galichet A., Pathologies involving the S100 proteins and RAGE Calcium Signalling and Disease 2007 45 93 138 Subcellular Biochemistry
32. Donato R., Intracellular and extracellular roles of S100 proteins Microscopy Research and Technique 2003 60 6 540 551
33. Zimmer D. B., Wright Sadosky P., Weber D. J., Molecular mechanisms of S100-target protein interactions Microscopy Research and Technique 2003 60 6 552 559
34. Marenholz I., Lovering R. C., Heizmann C. W., An update of the S100 nomenclature Biochimica et Biophysica Acta 2006 1763 11 1282 1283
35. Sugaya K., Fukagawa T., Matsumoto K.-I., Mita K., Takahashi E.-I., Ando A., Inoko H., Ikemura T., Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3 Genomics 1994 23 2 408 419
36. Hudson B. I., Carter A. M., Harja E., Kalea A. Z., Arriero M., Yang H., Grant P. J., Schmidt A. M., Identification, classification, and expression of RAGE gene splice variants The FASEB Journal 2008 22 5 1572 1580
37. Srikrishna G., Huttunen H. J., Johansson L., Weigle B., Yamaguchi Y., Rauvala H., Freeze H. H., N -glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth Journal of Neurochemistry 2002 80 6 998 1008
38. Wilton R., Yousef M. A., Saxena P., Szpunar M., Stevens F. J., Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli Protein Expression and Purification 2006 47 1 25 35
39. Osawa M., Yamamoto Y., Munesue S., Murakami N., Sakurai S., Watanabe T., Yonekura H., Uchigata Y., Iwamoto Y., Yamamoto H., De- N -glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts Biochimica et Biophysica Acta 2007 1770 10 1468 1474
40. Malherbe P., Richards J. G., Gaillard H., Thompson A., Diener C., Schuler A., Huber G., cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein Molecular Brain Research 1999 71 2 159 170
41. Yonekura H., Yamamoto Y., Sakurai S., Petrova R. G., Abedin M. D. J., Li H., Yasui K., Takeuchi M., Makita Z., Takasawa S., Okamoto H., Watanabe T., Yamamoto H., Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochemical Journal 2003 370 3 1097 1109
42. Schlueter C., Hauke S., Flohr A. M., Rogalla P., Bullerdiek J., Tissue-specific expression patterns of the RAGE receptor and its soluble formsa result of regulated alternative splicing? Biochimica et Biophysica Acta 2003 1630 1 1 6
43. Buckley S. T., Ehrhardt C., The receptor for advanced glycation end products (RAGE) and the lung Journal of Biomedicine Biotechnology 2010 2010 11
44. Ding Q., Keller J. N., Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain Neuroscience Letters 2005 373 1 67 72
45. Galichet A., Weibel M., Heizmann C. W., Calcium-regulated intramembrane proteolysis of the RAGE receptor Biochemical and Biophysical Research Communications 2008 370 1 1 5
46. Raucci A., Cugusi S., Antonelli A., Barabino S. M., Monti L., Bierhaus A., Reiss K., Saftig P., Bianchi M. E., A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) The FASEB Journal 2008 22 10 3716 3727
47. Zhang L., Bukulin M., Kojro E., Roth A., Metz V. V., Fahrenholz F., Nawroth P. P., Bierhaus A., Postina R., Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases The Journal of Biological Chemistry 2008 283 51 35507 35516
48. Emanuele E., D'Angelo A., Tomaino C., Binetti G., Ghidoni R., Politi P., Bernardi L., Maletta R., Bruni A. C., Geroldi D., Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia Archives of Neurology 2005 62 11 1734 1736 (Pubitemid 41626671)
49. Nozaki I., Watanabe T., Kawaguchi M., Akatsu H., Tsuneyama K., Yamamoto Y., Ohe K., Yonekura H., Yamada M., Yamamoto H., Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains Archives of Histology and Cytology 2007 70 5 279 290
50. Kojro E., Postina R., Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease Journal of Alzheimer's Disease 2009 16 4 865 878
51. Koyama H., Yamamoto H., Nishizawa Y., RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases Molecular Medicine 2007 13 11-12 625 635
52. Santilli F., Vazzana N., Bucciarelli L. G., Dav G., Soluble forms of RAGE in human diseases: clinical and therapeutical implications Current Medicinal Chemistry 2009 16 8 940 952
53. Tesaov P., Kalousov M., Jchymov M., Mestek O., Petruzelka L., Zima T., Receptor for advanced glycation end products (RAGE)soluble form (sRAGE) and gene polymorphisms in patients with breast cancer Cancer Investigation 2007 25 8 720 725 (Pubitemid 350223177)
54. Nakamura K., Yamagishi S.-I., Adachi H., Matsui T., Kurita-Nakamura Y., Takeuchi M., Inoue H., Imaizumi T., Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes Microvascular Research 2008 76 1 52 56
55. Bierhaus A., Nawroth P. P., Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications Diabetologia 2009 52 11 2251 2263
56. Ling L. R., Gooch C., Szabolcs M., Herold K. C., Lalla E., Hays A. P., Shi F. Y., Yan S. S. D., Schmidt A. M., RAGE: a journey from the complications of diabetes to disorders of the nervous systemstriking a fine balance between injury and repair Restorative Neurology and Neuroscience 2005 23 5-6 355 365
57. Ling L. R., Trojaborg W., Qu W., Kostov K., Shi D. Y., Gooch C., Szabolcs M., Hays A. P., Schmidt A. M., Antagonism of RAGE suppresses peripheral nerve regeneration The FASEB Journal 2004 18 15 1812 1817
58. Rong L. L., Yan S.-F., Wendt T., Hans D., Pachydaki S., Bucciarelli L. G., Adebayo A., Qu W., Lu Y., Rostov K., Lalla E., Shi D. Y., Gooch C., Szabolcs M., Trojaborg W., Hays A. P., Schmidt A. M., RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways The FASEB Journal 2004 18 15 1818 1825
59. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 1999 97 7 889 901
60. Dattilo B. M., Fritz G., Leclerc E., Vander Kooi C. W., Heizmann C. W., Chazin W. J., The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units Biochemistry 2007 46 23 6957 6970
61. Ostendorp T., Leclerc E., Galichet A., Koch M., Demling N., Weigle B., Heizmann C. W., Kroneck P. M. H., Fritz G., Structural and functional insights into RAGE activation by multimeric S100B The EMBO Journal 2007 26 16 3868 3878
62. Leclerc E., Fritz G., Weibel M., Heizmann C. W., Galichet A., S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains The Journal of Biological Chemistry 2007 282 43 31317 31331
63. Xie J., Reverdatto S., Frolov A., Hoffmann R., Burz D. S., Shekhtman A., Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) The Journal of Biological Chemistry 2008 283 40 27255 27269
64. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Yan S. D., Hofmann M., Yan S. F., Pischetsrieder M., Stern D., Schmidt A. M., N -(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression The Journal of Biological Chemistry 1999 274 44 31740 31749
65. Uetz-Von Allmen E., Koch M., Fritz G., Legler D. F., V domain of RAGE interacts with AGEs on prostate carcinoma cells Prostate 2008 68 7 748 758
66. Monteiro F. A., Cardoso I., Sousa M. M., Saraiva M. J., In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE) FEBS Letters 2006 580 14 3451 3456
67. Thinakaran G., Koo E. H., Amyloid precursor protein trafficking, processing, and function The Journal of Biological Chemistry 2008 283 44 29615 29619
68. Klein W. L., A toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets Neurochemistry International 2002 41 5 345 352
69. Dahlgren K. N., Manelli A. M., Blaine Stine W. Jr., Baker L. K., Krafft G. A., Ladu M. J., Oligomeric and fibrillar species of amyloid- peptides differentially affect neuronal viability The Journal of Biological Chemistry 2002 277 35 32046 32053
70. McLean C. A., Cherny R. A., Fraser F. W., Fuller S. J., Smith M. J., Beyreuther K., Bush A. I., Masters C. L., Soluble pool of A amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Annals of Neurology 1999 46 6 860 866
71. Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J., Ashe K. H., Natural oligomers of the amyloid- protein specifically disrupt cognitive function Nature Neuroscience 2005 8 1 79 84
72. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., Selkoe D. J., Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo Nature 2002 416 6880 535 539
73. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., Krafft G. A., Klein W. L., Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6448 6453
74. Huang T. H. J., Yang D.-S., Fraser P. E., Chakrabartty A., Alternate aggregation pathways of the Alzheimer -amyloid peptide: an in vitro model of preamyloid The Journal of Biological Chemistry 2000 275 46 36436 36440
75. Walsh D. M., Klyubin I., Fadeeva J. V., Rowan M. J., Selkoe D. J., Amyloid- oligomers: their production, toxicity and therapeutic inhibition Biochemical Society Transactions 2002 30 4 552 557
76. Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M., Teplow D. B., Selkoe D. J., Protofibrillar intermediates of amyloid -protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons Journal of Neuroscience 1999 19 20 8876 8884
77. Deshpande A., Mina E., Glabe C., Busciglio J., Different conformations of amyloid induce neurotoxicity by distinct mechanisms in human cortical neurons Journal of Neuroscience 2006 26 22 6011 6018
78. Wogulis M., Wright S., Cunningham D., Chilcote T., Powell K., Rydel R. E., Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death Journal of Neuroscience 2005 25 5 1071 1080
79. Moreira P. I., Duarte A. I., Santos M. S., Rego A. C., Oliveira C. R., An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease Journal of Alzheimer's Disease 2009 16 4 741 761
80. Reddy V. P., Zhu X., Perry G., Smith M. A., Oxidative stress in diabetes and Alzheimer's disease Journal of Alzheimer's Disease 2009 16 4 763 774
81. Hadding A., Kaltschmidt B., Kaltschmidt C., Overexpression of receptor of advanced glycation end products hypersensitizes cells for amyloid beta peptide-induced cell death Biochimica et Biophysica Acta 2004 1691 1 67 72
82. Hsia A. Y., Masliah E., Mcconlogue L., Yu G.-Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A., Mucke L., Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3228 3233
83. Arancio O., Zhang H. P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S. F., Stern A., Luddy J. S., Lue L.-F., Walker D. G., Roher A., Buttini M., Mucke L., Li W., Schmidt A. M., Kindy M., Hyslop P. A., Stern D. M., Yan S. S. D., RAGE potentiates A -induced perturbation of neuronal function in transgenic mice The EMBO Journal 2004 23 20 4096 4105
84. Vodopivec I., Galichet A., Knobloch M., Bierhaus A., Heizmann C. W., Nitsch R. M., RAGE does not affect amyloid pathology in transgenic arcA mice Neurodegenerative Diseases 2009 6 5-6 270 280
85. Knobloch M., Farinelli M., Konietzko U., Nitsch R. M., Mansuy I. M., A oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms Journal of Neuroscience 2007 27 29 7648 7653
86. Dearie R., Sagare A., Zlokovic B. V., The role of the cell surface LRP and soluble LRP in blood-brain barrier A clearance in Alzheimer's disease Current Pharmaceutical Design 2008 14 16 1601 1605
87. Moore B. W., A soluble protein characteristic of the nervous system Biochemical and Biophysical Research Communications 1965 19 6 739 744
88. Bell K., Shokrian D., Potenzieri C., Whitaker-Azmitia P. M., Harm avoidance, anxiety, and response to novelty in the adolescent S-100 transgenic mouse: role of serotonin and relevance to down syndrome Neuropsychopharmacology 2003 28 10 1810 1816
89. Nishiyama H., Takemura M., Takeda T., Itohara S., Normal development of serotonergic neurons in mice lacking S100B Neuroscience Letters 2002 321 1-2 49 52
90. Dyck R. H., Bogoch I. I., Marks A., Melvin N. R., Teskey G. C., Enhanced epileptogenesis in S100B knockout mice Molecular Brain Research 2002 106 1-2 22 29
91. Schaub M. C., Heizmann C. W., Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies Biochemical and Biophysical Research Communications 2008 369 1 247 264
92. Marenholz I., Heizmann C. W., Fritz G., S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) Biochemical and Biophysical Research Communications 2004 322 4 1111 1122
93. Krebs J., Heizmann C. W., Krebs J., Michalak M., Calcium-binding proteins and the EF-hand principle Calcium: A Matter of Life or Death 2007 Amsterdam, The Netherlands Elsevier 51 93
94. Gifford J. L., Walsh M. P., Vogel H. J., Structures and metal-ion-binding properties of the Ca2+ -binding helix-loop-helix EF-hand motifs Biochemical Journal 2007 405 2 199 221
95. Baudier J., Glasser N., Gerard D., Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein The Journal of Biological Chemistry 1986 261 18 8192 8203
96. Fritz G., Heizmann C. W., Messerschmidt A., Bode W., Cygler M., 3D structures of the calcium and zinc binding S100 proteins Handbook of Metalloproteins 2004 3 Chichester, UK John Wiley Sons 529 540
97. Senior S. Z., Mans L. L., VanGuilder H. D., Kelly K. A., Hendrich M. P., Elgren T. E., Catecholase activity associated with copper-S100B Biochemistry 2003 42 15 4392 4397
98. Heizmann C. W., Fritz G., Schfer B. W., S100 proteins: structure, functions and pathology Frontiers in Bioscience 2002 7 d1356 d1368
99. Nishikawa T., Lee I. S. M., Shiraishi N., Ishikawa T., Ohta Y., Nishikimi M., Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage The Journal of Biological Chemistry 1997 272 37 23037 23041
100. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I., S100B's double life: intracellular regulator and extracellular signal Biochimica et Biophysica Acta 2009 1793 6 1008 1022
101. Santamaria-Kisiel L., Rintala-Dempsey A. C., Shaw G. S., Calcium-dependent and -independent interactions of the S100 protein family Biochemical Journal 2006 396 2 201 214
102. Moroz O. V., Dodson G. G., Wilson K. S., Lukanidin E., Bronstein I. B., Multiple structural states of S100A12: a key to its functional diversity Microscopy Research and Technique 2003 60 6 581 592
103. Leukert N., Vogl T., Strupat K., Reichelt R., Sorg C., Roth J., Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity Journal of Molecular Biology 2006 359 4 961 972
104. Kizawa K., Takahara H., Troxler H., Kleinert P., Mochida U., Heizmann C. W., Specific citrullination causes assembly of a globular S100 A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle The Journal of Biological Chemistry 2008 283 8 5004 5013
105. Foell D., Wittkowski H., Vogl T., Roth J., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules Journal of Leukocyte Biology 2007 81 1 28 37
106. Zimmer D. B., Van Eldik L. J., Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation Journal of Cell Biology 1989 108 1 141 151
107. Davey G. E., Murmann P., Heizmann C. W., Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells The Journal of Biological Chemistry 2001 276 33 30819 30826
108. Rothermundt M., Peters M., Prehn J. H., Arolt V., S100B in brain damage and neurodegeneration Microscopy Research and Technique 2003 60 6 614 632
109. Rothermundt M., Ponath G., Arolt V., S100B in schizophrenic psychosis International Review of Neurobiology 2004 59 445 470
110. Hauschild A., Engel G., Brenner W., Glser R., Mnig H., Henze E., Christophers E., S100B protein detection in serum is a significant prognostic factor in metastatic melanoma Oncology 1999 56 4 338 344
111. Torabian S., Kashani-Sabet M., Biomarkers for melanoma Current Opinion in Oncology 2005 17 2 167 171
112. Van Eldik L. J., Zimmer D. B., Secretion of S-100 from rat C6 glioma cells Brain Research 1987 436 2 367 370
113. Gerlach R., Demel G., Knig H.-G., Gross U., Prehn J. H. M., Raabe A., Seifert V., Kgel D., Active secretion of S100B from astrocytes during metabolic stress Neuroscience 2006 141 4 1697 1701
114. Ciccarelli R., Di Iorio P., Bruno V., Battaglia G., D'Alimonte I., D'Onofrio M., Nicoletti F., Caciagli F., Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes Glia 1999 27 3 275 281
115. Whitaker-Azmitia P. M., Murphy R., Azmitia E. C., Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology Brain Research 1990 528 1 155 158
116. Edwards M. M., Robinson S. R., TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease Journal of Neural Transmission 2006 113 11 1709 1715
117. de Souza D. F., Leite M. C., Quincozes-Santos A., Nardin P., Tortorelli L. S., Rigo M. M., Gottfried C., Leal R. B., Gonalves C.-A., S100B secretion is stimulated by IL-1 in glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway Journal of Neuroimmunology 2009 206 1-2 52 57
118. Pea L. A., Brecher C. W., Marshak D. R., -amyloid regulates gene expression of glial trophic substance S100 in C6 glioma and primary astrocyte cultures Molecular Brain Research 1995 34 1 118 126
119. Iuvone T., Esposito G., De Filippis D., Bisogno T., Petrosino S., Scuderi C., Di Marzo V., Steardo L., Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro Journal of Molecular Medicine 2007 85 12 1379 1392
120. Pinto S. S., Gottfried C., Mendez A., Gonalves D., Karl J., Gonalves C. A., Wofchuk S., Rodnight R., Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology FEBS Letters 2000 486 3 203 207
121. de Almeida L. M., Pieiro C. C., Leite M. C., Brolese G., Tramontina F., Feoli A. M., Gottfried C., Gonalves C.-A., Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures Cellular and Molecular Neurobiology 2007 27 5 661 668
122. Abib R. T., Quincozes-Santos A., Nardin P., Wofchuk S. T., Perry M. L., Gonalves C.-A., Gottfried C., Epicatechin gallate increases glutamate uptake and S100B secretion in C6 cell lineage Molecular and Cellular Biochemistry 2008 310 1-2 153 158
123. Kligman D., Marshak D. R., Purification and characterization of a neurite extension factor from bovine brain Proceedings of the National Academy of Sciences of the United States of America 1985 82 20 7136 7139
124. Selinfreund R. H., Barger S. W., Pledger W. J., Van Eldik L. J., Neurotrophic protein S100 stimulates glial cell proliferation Proceedings of the National Academy of Sciences of the United States of America 1991 88 9 3554 3558
125. Tramontina F., Conte S., Gonalves D., Gottfried C., Portela L. V., Vinade L., Salbego C., Gonalves C.-A., Developmental changes in S100B content in brain tissue, cerebrospinal fluid, and astrocyte cultures of rats Cellular and Molecular Neurobiology 2002 22 3 373 378
126. Huttunen H. J., Kuja-Panula J., Sorci G., Agneletti A. L., Donato R., Rauvala H., Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation The Journal of Biological Chemistry 2000 275 51 40096 40105
127. Kgel D., Peters M., Knig H.-G., Hashemi S. M. A., Bui N. T., Arolt V., Rothermundt M., Prehn J. H. M., S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury Neuroscience 2004 127 4 913 920
128. Reali C., Scintu F., Pillai R., Donato R., Michetti F., Sogos V., S100B counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia Journal of Neuroscience Research 2005 81 5 677 686
129. Businaro R., Leone S., Fabrizi C., Sorci G., Donato R., Lauro G. M., Fumagalli L., S100B protects LAN-5 neuroblastoma cells against A amyloid-induced neurotoxicity via RAGE engagement at low doses but increases A amyloid neurotoxicity at high doses Journal of Neuroscience Research 2006 83 5 897 906
130. Ponath G., Schettler C., Kaestner F., Voigt B., Wentker D., Arolt V., Rothermundt M., Autocrine S100B effects on astrocytes are mediated via RAGE Journal of Neuroimmunology 2007 184 1-2 214 222
131. Feng L., Matsumoto C., Schwartz A., Schmidt A. M., Stern D. M., Pile-Spellman J., Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis Diabetes Care 2005 28 2 379 384
132. Man S., Ubogu E. E., Ransohoff R. M., Inflammatory cell migration into the central nervous system: a few new twists on an old tale Brain Pathology 2007 17 2 243 250
133. Marshak D. R., Pesce S. A., Stanley L. C., Griffin W. S. T., Increased S100 neurotrophic activity in Alzheimer's disease temporal lobe Neurobiology of Aging 1992 13 1 1 7
134. Peskind E. R., Griffin W. S. T., Akama K. T., Raskind M. A., Van Eldik L. J., Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease Neurochemistry International 2001 39 5-6 409 413
135. Chaves M. L., Camozzato A. L., Ferreira E. D., Piazenski I., Kochhann R., Dall'Igna O., Mazzini G. S., Souza D. O., Portela L. V., Serum levels of S100B and NSE proteins in Alzheimer's disease patients Journal of Neuroinflammation 2010 7, article 6
136. Griffin W. S. T., Sheng J. G., Mckenzie J. E., Royston M. C., Gentleman S. M., Brumback R. A., Cork L. C., Del Bigio M. R., Roberts G. W., Mrak R. E., Life-long overexpression of S100 in Down's syndrome: implications for Alzheimer pathogenesis Neurobiology of Aging 1998 19 5 401 405
137. Petzold A., Jenkins R., Watt H. C., Green A. J. E., Thompson E. J., Keir G., Fox N. C., Rossor M. N., Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease Neuroscience Letters 2003 336 3 167 170
138. Craft J. M., Watterson D. M., Marks A., Van Eldik L. J., Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human -amyloid Glia 2005 51 3 209 216
139. Mori T., Koyama N., Arendash G. W., Horikoshi-Sakuraba Y., Tan J., Town T., Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease Glia 2010 58 3 300 314
140. Baudier J., Cole R. D., Interactions between the microtubule-associated tau proteins and S100B regulate tau phosphorylation by the Ca2+ /calmodulin-dependent protein kinase II The Journal of Biological Chemistry 1988 263 12 5876 5883
141. Esposito G., Scuderi C., Lu J., Savani C., De Filippis D., Iuvone T., Steardo L. Jr., Sheen V., Steardo L., S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells Journal of Cellular and Molecular Medicine 2008 12 3 914 927
142. Mruthinti S., Sood A., Humphrey C. L., Swamy-Mruthinti S., Buccafusco J. J., The induction of surface -amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products Neuroscience 2006 142 2 463 473
143. Gasic-Milenkovic J., Dukic-Stefanovic S., Deuther-Conrad W., Grtner U., Mnch G., -amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line European Journal of Neuroscience 2003 17 4 813 821
144. Perrone L., Peluso G., Melone M. A. B., RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes Journal of Cellular Physiology 2008 217 1 60 71
145. Hsieh H.-L., Schfer B. W., Weigle B., Heizmann C. W., S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells Biochemical and Biophysical Research Communications 2004 316 3 949 959
146. Boyd J. H., Kan B., Roberts H., Wang Y., Walley K. R., S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products Circulation Research 2008 102 10 1239 1246
147. Ghavami S., Rashedi I., Dattilo B. M., Eshraghi M., Chazin W. J., Hashemi M., Wesselborg S., Kerkhoff C., Los M., S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway Journal of Leukocyte Biology 2008 83 6 1484 1492
148. Schmidt A. M., Yan S. D., Yan S. F., Stern D. M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses Journal of Clinical Investigation 2001 108 7 949 955
149. Westermark P., Benson M. D., Buxbaum J. N., Cohen A. S., Frangione B., Ikeda S.-I., Masters C. L., Merlini G., Saraiva M. J., Sipe J. D., A primer of amyloid nomenclature Amyloid 2007 14 3 179 183
150. Sousa M. M., Yan S. D., Fernandas R., Guimares A., Stern D., Saraiva M. J., Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways Journal of Neuroscience 2001 21 19 7576 7586
151. Schwarzman A. L., Tsiper M., Wente H., Wang A., Vitek M. P., Vasiliev V., Goldgaber D., Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants Amyloid 2004 11 1 1 9
152. Link C. D., Expression of human -amyloid peptide in transgenic Caenorhabditis elegans Proceedings of the National Academy of Sciences of the United States of America 1995 92 20 9368 9372
153. Stein T. D., Anders N. J., DeCarli C., Chan S. L., Mattson M. P., Johnson J. A., Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis Journal of Neuroscience 2004 24 35 7707 7717
154. Ehlermann P., Eggers K., Bierhaus A., Most P., Weichenhan D., Greten J., Nawroth P. P., Katus H. A., Remppis A., Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products Cardiovascular Diabetology 2006 5 6 15
155. Calcutt N. A., Cooper M. E., Kern T. S., Schmidt A. M., Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials Nature Reviews Drug Discovery 2009 8 5 417 429
156. Zlokovic B. V., New therapeutic targets in the neurovascular pathway in Alzheimer's disease Neurotherapeutics 2008 5 3 409 414